I am a
Home I AM A Search Login

Papers of the Week

Papers: 9 Jul 2022 - 15 Jul 2022

Human Studies

2022 Jul 12

J Neurol

Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors.


Gonzalez-Martinez A, Guerrero-Peral Á L, Arias-Rivas S, Silva L, Sierra Á, Gago-Veiga A B, García-Azorín D
J Neurol. 2022 Jul 12.
PMID: 35829760.


Headache is one of the most frequently reported symptoms in post-COVID patients. The clinical phenotype of COVID-19 headache combines phenotypic features of both tension-type headache (TTH) and migraine. We aimed to assess the effectiveness, side effects and predictors of amitriptyline (AMT) response in a real-world study setting.